merged_novo-nordisk-earnings-ozempic-wegovy.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The article does not specify the percentage of obesity drug sales from the US market.</other>
<question_number>2</question_number>
<answer>N/A</answer>
<other>The article does not state how many consecutive quarters Novo Nordisk was Europe’s most valuable company.</other>
<question_number>3</question_number>
<answer>N/A</answer>
<other>The article does not mention any other countries manufacturing semaglutide.</other>
<question_number>4</question_number>
<answer>N/A</answer>
<other>The article does not provide the total market capitalization.</other>
<question_number>5</question_number>
<answer>N/A</answer>
<other>The article does not state the number of participants in the CagriSema trial.</other>
<question_number>6</question_number>
<answer>$100 billion</answer>
<other>The article mentions an industry expectation of a market larger than $100 billion.</other>
<question_number>7</question_number>
<answer>N/A</answer>
<other>The article does not specify the number of manufacturing facilities.</other>
<question_number>8</question_number>
<answer>N/A</answer>
<other>The article does not provide a breakdown of prescriptions by physician type.</other>
<question_number>9</question_number>
<answer>N/A</answer>
<other>The article does not state the dollar value of Danish pharmaceutical exports.</other>
<question_number>10</question_number>
<answer>N/A</answer>
<other>The article does not specify the duration of the amycretin trial.</other>
<question_number>11</question_number>
<answer>1 Danish kroner = $0.1393</answer>
<other>Calculated as $40.6 billion / 290 billion Danish kroner.</other>
<question_number>12</question_number>
<answer>CagriSema</answer>
<other>The article states the CEO remained confident in the biology of CagriSema.</other>
<question_number>13</question_number>
<answer>President Trump's election</answer>
<other>The article states Trump’s election weighed on pharmaceutical companies.</other>
<question_number>14</question_number>
<answer>Denmark</answer>
<other>Novo Nordisk’s home country is Denmark, and Trump threatened tariffs on Denmark.</other>
<question_number>15</question_number>
<answer>16 percent</answer>
<other>The article states sales growth of 16 to 24 percent is expected in 2025.</other>
<question_number>16</question_number>
<answer>40 percent</answer>
<other>The article states the share price dropped about 40 percent.</other>
<question_number>17</question_number>
<answer>2</answer>
<other>Ozempic and Wegovy are explicitly named.</other>
<question_number>18</question_number>
<answer>United States</answer>
<other>The article states revenue jumped driven by growing sales in the United States.</other>
<question_number>19</question_number>
<answer>European Union</answer>
<other>The article states Trump warned tariffs on the European Union would “definitely happen.”</other>
<question_number>20</question_number>
<answer>Geopolitics</answer>
<other>The CFO stated geopolitics is more volatile currently.</other>